AT-001
- Generic Name
- AT-001
- Drug Type
- Small Molecule
- Chemical Formula
- C17H10F3N5O3S
- CAS Number
- 1355612-71-3
- Unique Ingredient Identifier
- E8I3O45DDU
- Background
AT-001 is under investigation in clinical trial NCT03062384 (AT-001 for Long-term Preservation of Brain Health in Aging).
Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 797
- Registration Number
- NCT05614349
- Locations
- ๐จ๐ฆ
The Governors of the University of Calgary, Calgary, Alberta, Canada
๐จ๐ฆUniversity of British Columbia, Vancouver, British Columbia, Canada
๐จ๐ฆThe University of Manitoba, Winnipeg, Manitoba, Canada
Cardiovascular Effects of COVID-19
- First Posted Date
- 2020-04-28
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 81
- Registration Number
- NCT04365699
- Locations
- ๐บ๐ธ
NYU Langone Health, New York, New York, United States
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
- Conditions
- Diabetic Cardiomyopathies
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2022-12-08
- Lead Sponsor
- Applied Therapeutics, Inc.
- Target Recruit Count
- 675
- Registration Number
- NCT04083339
- Locations
- ๐บ๐ธ
University of California, San Diego (UCSD), La Jolla, California, United States
๐บ๐ธUniversity of California - Irvine Medical Center, Orange, California, United States
๐บ๐ธClinical Trials Research, Lincoln, California, United States
Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study
- Conditions
- Oral SubMucous Fibrosis
- Interventions
- First Posted Date
- 2016-03-21
- Last Posted Date
- 2016-03-21
- Lead Sponsor
- The Oxford Dental College, Hospital and Research Center, Bangalore, India
- Target Recruit Count
- 74
- Registration Number
- NCT02714543
Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2014-01-23
- Lead Sponsor
- Alltech Life Sciences Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01731093
- Locations
- ๐บ๐ธ
University of Kentucky Alzheimer's Disease Research Center, Lexington, Kentucky, United States
The DIEP Flap as a Model of Ischemia-Reperfusion: an Intervention Study
- Conditions
- Ischemia-Reperfusion
- Interventions
- First Posted Date
- 2009-01-13
- Last Posted Date
- 2009-01-13
- Lead Sponsor
- Maastricht University Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00821158
- Locations
- ๐ณ๐ฑ
Maastricht University Medical Center, Maastricht, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.